Journal of gastrointestinal and liver diseases : JGLD
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease, Anti-TNF, and Medications. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of gastrointestinal and liver diseases : JGLD
AuthorsAlex Arenas, Diego Ruedi, Gustavo Walsen +1 more
InstitutionUnit of Gastroenterology. Internal Medicine Department. Faculty of Medicine. Clínica Alemana - Universidad del Desarrollo; Chile. afarenas@gmail.com.
Study typeLetter
Indexed viaPubMed
Source typeResearch paper
PublishedSep 26, 2026, 12:00 AM
Content availableMetadata only
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Dual Therapy for Complex Inflammatory Bowel Disease: Safety, Clinical and Steroid-Free Response
Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Medications. The original article is from Clinical and experimental gastroenterology.
Methodological and respiratory concerns regarding JAK inhibitor safety in ulcerative colitis.
Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and JAK inhibitor. The original article is from Journal of Crohn's & colitis.
Evaluation of the efficacy and safety of the combined use of 5-aminosalicylic acid and genetically engineered biological drugs in patients with moderate ulcerative colitis
Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Medications. The original article is from Therapy.